Brazil approved the country’s first generic version of Novo Nordisk A/S’s Ozempic shot, opening the door to cheaper competition in one of the world’s fastest-growing markets for weight loss and diabetes drugs. For the full story, visit the source.
Health
Brazil Clears First Generic Copy of Novo Nordisk’s Ozempic Shot
Brazil approved the country’s first generic version of Novo Nordisk A/S’s Ozempic shot, opening the door to cheaper competition in one of the world’s fastest-growing markets for weight loss and diabetes drugs.
By Bloomberg News· Financial Post· 2 days ago· 2 min read
This summary is sourced from Financial Post. Read the full article at:Financial Post